These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 22721706)

  • 1. Novel atypical PKC inhibitors prevent vascular endothelial growth factor-induced blood-retinal barrier dysfunction.
    Titchenell PM; Lin CM; Keil JM; Sundstrom JM; Smith CD; Antonetti DA
    Biochem J; 2012 Sep; 446(3):455-67. PubMed ID: 22721706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Norrin restores blood-retinal barrier properties after vascular endothelial growth factor-induced permeability.
    Díaz-Coránguez M; Lin CM; Liebner S; Antonetti DA
    J Biol Chem; 2020 Apr; 295(14):4647-4660. PubMed ID: 32086377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmalemma Vesicle-Associated Protein Has a Key Role in Blood-Retinal Barrier Loss.
    Wisniewska-Kruk J; van der Wijk AE; van Veen HA; Gorgels TG; Vogels IM; Versteeg D; Van Noorden CJ; Schlingemann RO; Klaassen I
    Am J Pathol; 2016 Apr; 186(4):1044-54. PubMed ID: 26878208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase cβ phosphorylates occludin regulating tight junction trafficking in vascular endothelial growth factor-induced permeability in vivo.
    Murakami T; Frey T; Lin C; Antonetti DA
    Diabetes; 2012 Jun; 61(6):1573-83. PubMed ID: 22438576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor-A
    Ved N; Hulse RP; Bestall SM; Donaldson LF; Bainbridge JW; Bates DO
    Clin Sci (Lond); 2017 Jun; 131(12):1225-1243. PubMed ID: 28341661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
    Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
    Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood-retinal barrier breakdown induced by activation of protein kinase C via vascular endothelial growth factor in streptozotocin-induced diabetic rats.
    Xu X; Zhu Q; Xia X; Zhang S; Gu Q; Luo D
    Curr Eye Res; 2004 Apr; 28(4):251-6. PubMed ID: 15259294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability.
    Harhaj NS; Felinski EA; Wolpert EB; Sundstrom JM; Gardner TW; Antonetti DA
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):5106-15. PubMed ID: 17065532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of protein kinase C-ζ attenuates vascular leakage via prevention of tight junction protein decrease in diabetic retinopathy.
    Song HB; Jun HO; Kim JH; Yu YS; Kim KW; Kim JH
    Biochem Biophys Res Commun; 2014 Jan; 444(1):63-8. PubMed ID: 24434146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of protein kinase C delta attenuates blood-retinal barrier breakdown in diabetic retinopathy.
    Kim JH; Kim JH; Jun HO; Yu YS; Kim KW
    Am J Pathol; 2010 Mar; 176(3):1517-24. PubMed ID: 20110406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of protein kinase C is not sufficient to prevent or reverse effects of VEGF165 on claudin-1 and permeability in microvascular retinal endothelial cells.
    Deissler HL; Deissler H; Lang GE
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):535-42. PubMed ID: 19643968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Atypical Protein Kinase C Reduces Inflammation-Induced Retinal Vascular Permeability.
    Lin CM; Titchenell PM; Keil JM; Garcia-Ocaña A; Bolinger MT; Abcouwer SF; Antonetti DA
    Am J Pathol; 2018 Oct; 188(10):2392-2405. PubMed ID: 30220554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PHD2 attenuates high-glucose-induced blood retinal barrier breakdown in human retinal microvascular endothelial cells by regulating the Hif-1α/VEGF pathway.
    Li J; Lu X; Wei L; Ye D; Lin J; Tang X; Cui K; Yu S; Xu Y; Liang X
    Inflamm Res; 2022 Jan; 71(1):69-79. PubMed ID: 34773469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoids exert differential effects on the endothelium in an in vitro model of the blood-retinal barrier.
    van der Wijk AE; Canning P; van Heijningen RP; Vogels IMC; van Noorden CJF; Klaassen I; Schlingemann RO
    Acta Ophthalmol; 2019 Mar; 97(2):214-224. PubMed ID: 30168271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EphrinA1 inhibits vascular endothelial growth factor-induced intracellular signaling and suppresses retinal neovascularization and blood-retinal barrier breakdown.
    Ojima T; Takagi H; Suzuma K; Oh H; Suzuma I; Ohashi H; Watanabe D; Suganami E; Murakami T; Kurimoto M; Honda Y; Yoshimura N
    Am J Pathol; 2006 Jan; 168(1):331-9. PubMed ID: 16400034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Single Routes of Intracellular Signaling is Not Sufficient to Neutralize the Biphasic Disturbance of a Retinal Endothelial Cell Barrier Induced by VEGF-A165.
    Deissler HL; Lang GK; Lang GE
    Cell Physiol Biochem; 2017; 42(4):1493-1513. PubMed ID: 28719888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of azurocidin as a permeability factor in the retina: involvement in VEGF-induced and early diabetic blood-retinal barrier breakdown.
    Skondra D; Noda K; Almulki L; Tayyari F; Frimmel S; Nakazawa T; Kim IK; Zandi S; Thomas KL; Miller JW; Gragoudas ES; Hafezi-Moghadam A
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):726-31. PubMed ID: 18235021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and structure-activity relationships of thieno[2,3-d]pyrimidines as atypical protein kinase C inhibitors to control retinal vascular permeability and cytokine-induced edema.
    Liu X; Wilson MW; Liu K; Lee P; Yeomans L; Hagen SE; Lin CM; Wen B; Sun D; White AD; Showalter HD; Antonetti DA
    Bioorg Med Chem; 2020 Jun; 28(11):115480. PubMed ID: 32327351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effects of the Src inhibitor, dasatinib, on breakdown of the blood-retinal barrier.
    Kim SR; Suh W
    Arch Pharm Res; 2017 Feb; 40(2):197-203. PubMed ID: 27988882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decursin inhibits VEGF-mediated inner blood-retinal barrier breakdown by suppression of VEGFR-2 activation.
    Kim JH; Kim JH; Lee YM; Ahn EM; Kim KW; Yu YS
    J Cereb Blood Flow Metab; 2009 Sep; 29(9):1559-67. PubMed ID: 19536074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.